Chimeric Construct Engineering with Human Variant HLA-A*02:01:01:01

Author:

Karkischenko V. N.1,Petrova N. V.1,Savchenko E. S.1,Ogneva N. S.1,Koloskova E. M.2,Maksimenko S. V.1,Manuvera V. A.3,Bobrovsky P. A.3,Lazarev V. N.3

Affiliation:

1. Scientifi c Center of Biomedical Technologies of the Federal Medical and Biological Agency of Russia

2. All-Russian Research Institute of Physiology, Biochemistry and Animal Nutrition — branch of the Federal Scientifi c Centre of Animal Husbandry — All-Russian Institute of Animal Husbandry named after acad. L.K. Ernst

3. Federal Research and Clinical Centre of Physical-Chemical Medicine of the Federal Medical and Biological Agency of Russia

Publisher

Scientific Center for Biomedical Technologies of the Federal Medical-Biological Agency

Subject

General Medicine

Reference26 articles.

1. Dulya M.S., Karkischenko V.N., Khvostov D.V., Ageldinov R.A., Karkischenko N.N. Tsitokinovyy profil’ laboratornykh inbrednykh i transgennykh myshey v otsenke immunologicheskogo statusa i poiske novykh farmakologicheskikh regulyatorov [Cytokine Profile of Laboratory Inbred and Transgenic Mice in the Evaluation of the Immunological Status and Search for New Pharmacological Regulators]. Biomeditsina [Journal Biomed]. 2019; 15(2):54-62. (In Russian). DOI: 10.33647/2074-5982-15-2-54-62.

2. Karkischenko V.N., Bolotskikh L.A., Kapanadze G.D., Karkischenko N.N., Koloskova E.M., Maksimenko S.V., Matveyenko E.L., Petrova N.V., Ryabykh V.P., Revyakin A.O., Stankova N.V., Semenov Kh.Kh. Sozdaniye liniy transgennykh zhivot-nykh-modeley s genami cheloveka NAT1 i NAT2 [Creation of lines of transgenic animal models with human genes NAT1 and NAT2]. Biomeditsina [Journal Biomed]. 2016;1:74-84. (In Russian).

3. Karkischenko V.N., Pomytkin I.A., Skvortsova V.I. Opioidergicheskaya sistema immunnykh kletok: no-vaya farmakologicheskaya mishen’ v terapii «tsitokinovogo shtorma» [The Opioidergic System of Immune Cells: A New Pharmacological Target in the Therapy of “Cytokine Storm”]. Biomeditsina [Journal Biomed]. 2020;16(4):14-23. (In Russian). DOI: 10.33647/2074-5982-16-4-14-23.

4. Karkischenko V.N., Ryabykh V.P., Bolotskikh L.A., Semenov Kh.Kh., Kapanadze G.D., Petrova N.V., Ezerskiy V.A., Zhukova O.B., Koloskova E.M., Maksimenko S.V., Stolyarova V.N., Trubitsyna T.P. Fiziologo-embriologicheskiye aspekty sozdaniya transgennykh myshey s integrirovannymi genami NAT1 i NAT2 cheloveka [Physiological and embryological aspects of creating transgenic mice with integrated human NAT1 and NAT2 genes]. Biomeditsina [Journal Biomed]. 2016;1:52-65. (In Russian).

5. arkischenko V.N., Ryabykh V.P., Karkischenko N.N., Dulya M.S., Ezerskiy V.A., Koloskova E.M., Lazarev V.N., Maksimenko S.V., Petrova N.V., Stolyarova V.N., Trubitsyna T.P. Molekulyarno-geneticheskie aspekty tekhnologii polucheniya transgennykh myshej s in-tegrirovannymi genami N-atsetiltransferazy (NAT1 i NAT2) cheloveka [Molecular and genetic aspects of the technology for producing transgenic mice with integrated genes of human N-acetyltransferase (NAT1 and NAT2)]. Biomeditsina [Journal Biomed]. 2016;1:4-17. (In Russian).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3